Global Radioligand Therapy Supply, Demand and Key Producers, 2023-2029

Page: 114

Published Date: 05 Aug 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Radioligand Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Radioligand Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radioligand Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radioligand Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Radioligand Therapy total market, 2018-2029, (USD Million)
Global Radioligand Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Radioligand Therapy total market, key domestic companies and share, (USD Million)
Global Radioligand Therapy revenue by player and market share 2018-2023, (USD Million)
Global Radioligand Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Radioligand Therapy total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Radioligand Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Advanced Accelerator Applications, Mercy Radiology, POINT Biopharma Global Inc, Fusion Pharma, Telix Pharmaceuticals Ltd, Lantheus Holdings, Inc, Bayer AG and Curium Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radioligand Therapy market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Radioligand Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Radioligand Therapy Market, Segmentation by Type
Actinium 225 (Ac-225)
Lutetium 177 (Lu-177)
Gallium 68 (Ga-68)
Fluorine 18 (F-18)
Other Radionuclides

Global Radioligand Therapy Market, Segmentation by Application
Neuroendocrine Neoplasms
Prostate Cancer

Companies Profiled:
Novartis
Advanced Accelerator Applications
Mercy Radiology
POINT Biopharma Global Inc
Fusion Pharma
Telix Pharmaceuticals Ltd
Lantheus Holdings, Inc
Bayer AG
Curium Pharma
Precirix

Key Questions Answered
1. How big is the global Radioligand Therapy market?
2. What is the demand of the global Radioligand Therapy market?
3. What is the year over year growth of the global Radioligand Therapy market?
4. What is the total value of the global Radioligand Therapy market?
5. Who are the major players in the global Radioligand Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Radioligand Therapy Introduction
    1.2 World Radioligand Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Radioligand Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Radioligand Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Radioligand Therapy Market Size (2018-2029)
        1.3.3 China Radioligand Therapy Market Size (2018-2029)
        1.3.4 Europe Radioligand Therapy Market Size (2018-2029)
        1.3.5 Japan Radioligand Therapy Market Size (2018-2029)
        1.3.6 South Korea Radioligand Therapy Market Size (2018-2029)
        1.3.7 ASEAN Radioligand Therapy Market Size (2018-2029)
        1.3.8 India Radioligand Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Radioligand Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Radioligand Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Radioligand Therapy Consumption Value (2018-2029)
    2.2 World Radioligand Therapy Consumption Value by Region
        2.2.1 World Radioligand Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Radioligand Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Radioligand Therapy Consumption Value (2018-2029)
    2.4 China Radioligand Therapy Consumption Value (2018-2029)
    2.5 Europe Radioligand Therapy Consumption Value (2018-2029)
    2.6 Japan Radioligand Therapy Consumption Value (2018-2029)
    2.7 South Korea Radioligand Therapy Consumption Value (2018-2029)
    2.8 ASEAN Radioligand Therapy Consumption Value (2018-2029)
    2.9 India Radioligand Therapy Consumption Value (2018-2029)

3 World Radioligand Therapy Companies Competitive Analysis
    3.1 World Radioligand Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Radioligand Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Radioligand Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Radioligand Therapy in 2022
    3.3 Radioligand Therapy Company Evaluation Quadrant
    3.4 Radioligand Therapy Market: Overall Company Footprint Analysis
        3.4.1 Radioligand Therapy Market: Region Footprint
        3.4.2 Radioligand Therapy Market: Company Product Type Footprint
        3.4.3 Radioligand Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Radioligand Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Radioligand Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Radioligand Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Radioligand Therapy Consumption Value Comparison
        4.2.1 United States VS China: Radioligand Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Radioligand Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Radioligand Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Radioligand Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Radioligand Therapy Revenue, (2018-2023)
    4.4 China Based Companies Radioligand Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Radioligand Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Radioligand Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Radioligand Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Radioligand Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Radioligand Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Radioligand Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Actinium 225 (Ac-225)
        5.2.2 Lutetium 177 (Lu-177)
        5.2.3 Gallium 68 (Ga-68)
        5.2.4 Fluorine 18 (F-18)
        5.2.5 Other Radionuclides
    5.3 Market Segment by Type
        5.3.1 World Radioligand Therapy Market Size by Type (2018-2023)
        5.3.2 World Radioligand Therapy Market Size by Type (2024-2029)
        5.3.3 World Radioligand Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Radioligand Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Neuroendocrine Neoplasms
        6.2.2 Prostate Cancer
    6.3 Market Segment by Application
        6.3.1 World Radioligand Therapy Market Size by Application (2018-2023)
        6.3.2 World Radioligand Therapy Market Size by Application (2024-2029)
        6.3.3 World Radioligand Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis Radioligand Therapy Product and Services
        7.1.4 Novartis Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 Advanced Accelerator Applications
        7.2.1 Advanced Accelerator Applications Details
        7.2.2 Advanced Accelerator Applications Major Business
        7.2.3 Advanced Accelerator Applications Radioligand Therapy Product and Services
        7.2.4 Advanced Accelerator Applications Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Advanced Accelerator Applications Recent Developments/Updates
        7.2.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
    7.3 Mercy Radiology
        7.3.1 Mercy Radiology Details
        7.3.2 Mercy Radiology Major Business
        7.3.3 Mercy Radiology Radioligand Therapy Product and Services
        7.3.4 Mercy Radiology Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Mercy Radiology Recent Developments/Updates
        7.3.6 Mercy Radiology Competitive Strengths & Weaknesses
    7.4 POINT Biopharma Global Inc
        7.4.1 POINT Biopharma Global Inc Details
        7.4.2 POINT Biopharma Global Inc Major Business
        7.4.3 POINT Biopharma Global Inc Radioligand Therapy Product and Services
        7.4.4 POINT Biopharma Global Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 POINT Biopharma Global Inc Recent Developments/Updates
        7.4.6 POINT Biopharma Global Inc Competitive Strengths & Weaknesses
    7.5 Fusion Pharma
        7.5.1 Fusion Pharma Details
        7.5.2 Fusion Pharma Major Business
        7.5.3 Fusion Pharma Radioligand Therapy Product and Services
        7.5.4 Fusion Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Fusion Pharma Recent Developments/Updates
        7.5.6 Fusion Pharma Competitive Strengths & Weaknesses
    7.6 Telix Pharmaceuticals Ltd
        7.6.1 Telix Pharmaceuticals Ltd Details
        7.6.2 Telix Pharmaceuticals Ltd Major Business
        7.6.3 Telix Pharmaceuticals Ltd Radioligand Therapy Product and Services
        7.6.4 Telix Pharmaceuticals Ltd Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Telix Pharmaceuticals Ltd Recent Developments/Updates
        7.6.6 Telix Pharmaceuticals Ltd Competitive Strengths & Weaknesses
    7.7 Lantheus Holdings, Inc
        7.7.1 Lantheus Holdings, Inc Details
        7.7.2 Lantheus Holdings, Inc Major Business
        7.7.3 Lantheus Holdings, Inc Radioligand Therapy Product and Services
        7.7.4 Lantheus Holdings, Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Lantheus Holdings, Inc Recent Developments/Updates
        7.7.6 Lantheus Holdings, Inc Competitive Strengths & Weaknesses
    7.8 Bayer AG
        7.8.1 Bayer AG Details
        7.8.2 Bayer AG Major Business
        7.8.3 Bayer AG Radioligand Therapy Product and Services
        7.8.4 Bayer AG Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Bayer AG Recent Developments/Updates
        7.8.6 Bayer AG Competitive Strengths & Weaknesses
    7.9 Curium Pharma
        7.9.1 Curium Pharma Details
        7.9.2 Curium Pharma Major Business
        7.9.3 Curium Pharma Radioligand Therapy Product and Services
        7.9.4 Curium Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Curium Pharma Recent Developments/Updates
        7.9.6 Curium Pharma Competitive Strengths & Weaknesses
    7.10 Precirix
        7.10.1 Precirix Details
        7.10.2 Precirix Major Business
        7.10.3 Precirix Radioligand Therapy Product and Services
        7.10.4 Precirix Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Precirix Recent Developments/Updates
        7.10.6 Precirix Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Radioligand Therapy Industry Chain
    8.2 Radioligand Therapy Upstream Analysis
    8.3 Radioligand Therapy Midstream Analysis
    8.4 Radioligand Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Radioligand Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Radioligand Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Radioligand Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Radioligand Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Radioligand Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Radioligand Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Radioligand Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Radioligand Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Radioligand Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Radioligand Therapy Players in 2022
    Table 12. World Radioligand Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Radioligand Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Radioligand Therapy Player
    Table 15. Radioligand Therapy Market: Company Product Type Footprint
    Table 16. Radioligand Therapy Market: Company Product Application Footprint
    Table 17. Radioligand Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Radioligand Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Radioligand Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Radioligand Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Radioligand Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Radioligand Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Radioligand Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Radioligand Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Radioligand Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Radioligand Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Radioligand Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Radioligand Therapy Revenue Market Share (2018-2023)
    Table 29. World Radioligand Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Radioligand Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Radioligand Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Radioligand Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Radioligand Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Radioligand Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Novartis Basic Information, Area Served and Competitors
    Table 36. Novartis Major Business
    Table 37. Novartis Radioligand Therapy Product and Services
    Table 38. Novartis Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Novartis Recent Developments/Updates
    Table 40. Novartis Competitive Strengths & Weaknesses
    Table 41. Advanced Accelerator Applications Basic Information, Area Served and Competitors
    Table 42. Advanced Accelerator Applications Major Business
    Table 43. Advanced Accelerator Applications Radioligand Therapy Product and Services
    Table 44. Advanced Accelerator Applications Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Advanced Accelerator Applications Recent Developments/Updates
    Table 46. Advanced Accelerator Applications Competitive Strengths & Weaknesses
    Table 47. Mercy Radiology Basic Information, Area Served and Competitors
    Table 48. Mercy Radiology Major Business
    Table 49. Mercy Radiology Radioligand Therapy Product and Services
    Table 50. Mercy Radiology Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Mercy Radiology Recent Developments/Updates
    Table 52. Mercy Radiology Competitive Strengths & Weaknesses
    Table 53. POINT Biopharma Global Inc Basic Information, Area Served and Competitors
    Table 54. POINT Biopharma Global Inc Major Business
    Table 55. POINT Biopharma Global Inc Radioligand Therapy Product and Services
    Table 56. POINT Biopharma Global Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. POINT Biopharma Global Inc Recent Developments/Updates
    Table 58. POINT Biopharma Global Inc Competitive Strengths & Weaknesses
    Table 59. Fusion Pharma Basic Information, Area Served and Competitors
    Table 60. Fusion Pharma Major Business
    Table 61. Fusion Pharma Radioligand Therapy Product and Services
    Table 62. Fusion Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Fusion Pharma Recent Developments/Updates
    Table 64. Fusion Pharma Competitive Strengths & Weaknesses
    Table 65. Telix Pharmaceuticals Ltd Basic Information, Area Served and Competitors
    Table 66. Telix Pharmaceuticals Ltd Major Business
    Table 67. Telix Pharmaceuticals Ltd Radioligand Therapy Product and Services
    Table 68. Telix Pharmaceuticals Ltd Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Telix Pharmaceuticals Ltd Recent Developments/Updates
    Table 70. Telix Pharmaceuticals Ltd Competitive Strengths & Weaknesses
    Table 71. Lantheus Holdings, Inc Basic Information, Area Served and Competitors
    Table 72. Lantheus Holdings, Inc Major Business
    Table 73. Lantheus Holdings, Inc Radioligand Therapy Product and Services
    Table 74. Lantheus Holdings, Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Lantheus Holdings, Inc Recent Developments/Updates
    Table 76. Lantheus Holdings, Inc Competitive Strengths & Weaknesses
    Table 77. Bayer AG Basic Information, Area Served and Competitors
    Table 78. Bayer AG Major Business
    Table 79. Bayer AG Radioligand Therapy Product and Services
    Table 80. Bayer AG Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Bayer AG Recent Developments/Updates
    Table 82. Bayer AG Competitive Strengths & Weaknesses
    Table 83. Curium Pharma Basic Information, Area Served and Competitors
    Table 84. Curium Pharma Major Business
    Table 85. Curium Pharma Radioligand Therapy Product and Services
    Table 86. Curium Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Curium Pharma Recent Developments/Updates
    Table 88. Precirix Basic Information, Area Served and Competitors
    Table 89. Precirix Major Business
    Table 90. Precirix Radioligand Therapy Product and Services
    Table 91. Precirix Radioligand Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Radioligand Therapy Upstream (Raw Materials)
    Table 93. Radioligand Therapy Typical Customers
List of Figure
    Figure 1. Radioligand Therapy Picture
    Figure 2. World Radioligand Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Radioligand Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Radioligand Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Radioligand Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Radioligand Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Radioligand Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Radioligand Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Radioligand Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Radioligand Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Radioligand Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Radioligand Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Radioligand Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Radioligand Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Radioligand Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Radioligand Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Radioligand Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Radioligand Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Radioligand Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Radioligand Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Radioligand Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Radioligand Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Radioligand Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Radioligand Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Radioligand Therapy Markets in 2022
    Figure 27. United States VS China: Radioligand Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Radioligand Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Radioligand Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Radioligand Therapy Market Size Market Share by Type in 2022
    Figure 31. Actinium 225 (Ac-225)
    Figure 32. Lutetium 177 (Lu-177)
    Figure 33. Gallium 68 (Ga-68)
    Figure 34. Fluorine 18 (F-18)
    Figure 35. Other Radionuclides
    Figure 36. World Radioligand Therapy Market Size Market Share by Type (2018-2029)
    Figure 37. World Radioligand Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Radioligand Therapy Market Size Market Share by Application in 2022
    Figure 39. Neuroendocrine Neoplasms
    Figure 40. Prostate Cancer
    Figure 41. Radioligand Therapy Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Advanced Accelerator Applications
Mercy Radiology
POINT Biopharma Global Inc
Fusion Pharma
Telix Pharmaceuticals Ltd
Lantheus Holdings, Inc
Bayer AG
Curium Pharma
Precirix

Related Reports

Global Radioligand Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Radioligand Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 05 Aug 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Radioligand Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Radioligand Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Radioligand Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Radioligand Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Radioligand Therapy

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>